Literature DB >> 29024071

An unjustified benefit: immortal time bias in the analysis of time-dependent events.

Andreas Gleiss1, Rainer Oberbauer2, Georg Heinze1.   

Abstract

Immortal time bias is a problem arising from methodologically wrong analyses of time-dependent events in survival analyses. We illustrate the problem by analysis of a kidney transplantation study. Following patients from transplantation to death, groups defined by the occurrence or nonoccurrence of graft failure during follow-up seemingly had equal overall mortality. Such naive analysis assumes that patients were assigned to the two groups at time of transplantation, which actually are a consequence of occurrence of a time-dependent event later during follow-up. We introduce landmark analysis as the method of choice to avoid immortal time bias. Landmark analysis splits the follow-up time at a common, prespecified time point, the so-called landmark. Groups are then defined by time-dependent events having occurred before the landmark, and outcome events are only considered if occurring after the landmark. Landmark analysis can be easily implemented with common statistical software. In our kidney transplantation example, landmark analyses with landmarks set at 30 and 60 months clearly identified graft failure as a risk factor for overall mortality. We give further typical examples from transplantation research and discuss strengths and limitations of landmark analysis and other methods to address immortal time bias such as Cox regression with time-dependent covariables.
© 2017 Steunstichting ESOT.

Entities:  

Keywords:  immortal time bias; landmark analysis; survival analysis; time-dependent events

Mesh:

Year:  2017        PMID: 29024071     DOI: 10.1111/tri.13081

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  44 in total

1.  Landmark analysis: A primer.

Authors:  Charity J Morgan
Journal:  J Nucl Cardiol       Date:  2019-02-04       Impact factor: 5.952

2.  Prognosticating outcomes and survival for patients with lumbar spinal metastases: Results of a bayesian regression analysis.

Authors:  Andrew J Schoenfeld; Marco L Ferrone; Joseph H Schwab; Justin A Blucher; Lauren B Barton; Mitchel B Harris; James D Kang
Journal:  Clin Neurol Neurosurg       Date:  2019-04-22       Impact factor: 1.876

3.  No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy.

Authors:  Siddharth Singh; Jihoon Kim; Wenhong Zhu; Parambir S Dulai; William J Sandborn; Vipul Jairath
Journal:  Aliment Pharmacol Ther       Date:  2020-06-23       Impact factor: 8.171

4.  Association between diverticular disease requiring surgical intervention and mortality in the postlung transplant population - a retrospective cohort study.

Authors:  Laneshia K Tague; William Adams; Katherine A Young; Oh Jin Kwon; Erin Mahoney; Erin M Lowery
Journal:  Transpl Int       Date:  2019-03-25       Impact factor: 3.782

5.  The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study.

Authors:  David J Taber; Zemin Su; James N Fleming; Nicole A Pilch; Thomas Morinelli; Patrick Mauldin; Derek Dubay
Journal:  Transpl Int       Date:  2018-09-16       Impact factor: 3.782

6.  Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis.

Authors:  Seung Woo Kim; Young-Chul Choi; Seung Min Kim; Hyo Sup Shim; Ha Young Shin
Journal:  J Neurol       Date:  2019-02-06       Impact factor: 4.849

7.  Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.

Authors:  Amit G Singal; Nicole E Rich; Neil Mehta; Andrea D Branch; Anjana Pillai; Maarouf Hoteit; Michael Volk; Mobolaji Odewole; Steven Scaglione; Jennifer Guy; Adnan Said; Jordan J Feld; Binu V John; Catherine Frenette; Parvez Mantry; Amol S Rangnekar; Omobonike Oloruntoba; Michael Leise; Janice H Jou; Kalyan Ram Bhamidimarri; Laura Kulik; George N Ioannou; Annsa Huang; Tram Tran; Hrishikesh Samant; Renumathy Dhanasekaran; Andres Duarte-Rojo; Reena Salgia; Sheila Eswaran; Prasun Jalal; Avegail Flores; Sanjaya K Satapathy; Sofia Kagan; Purva Gopal; Robert Wong; Neehar D Parikh; Caitlin C Murphy
Journal:  Gastroenterology       Date:  2019-07-30       Impact factor: 22.682

8.  Use of Direct-Acting Antiviral Agents and Survival Among Medicare Beneficiaries with Dementia and Chronic Hepatitis C.

Authors:  Linh Tran; Jeah Jung; Caroline Carlin; Sunmin Lee; Chen Zhao; Roger Feldman
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C.

Authors:  Yamini Kalidindi; Jeah Jung; Roger Feldman; Thomas Riley
Journal:  JAMA Netw Open       Date:  2020-07-01

10.  Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.

Authors:  Amit G Singal; Nicole E Rich; Neil Mehta; Andrea Branch; Anjana Pillai; Maarouf Hoteit; Michael Volk; Mobolaji Odewole; Steven Scaglione; Jennifer Guy; Adnan Said; Jordan J Feld; Binu V John; Catherine Frenette; Parvez Mantry; Amol S Rangnekar; Omobonike Oloruntoba; Michael Leise; Janice H Jou; Kalyan Ram Bhamidimarri; Laura Kulik; Tram Tran; Hrishikesh Samant; Renumathy Dhanasekaran; Andres Duarte-Rojo; Reena Salgia; Sheila Eswaran; Prasun Jalal; Avegail Flores; Sanjaya K Satapathy; Robert Wong; Annsa Huang; Suresh Misra; Myron Schwartz; Robert Mitrani; Sasank Nakka; Wassim Noureddine; Chanda Ho; Venkata R Konjeti; Alexander Dao; Kevin Nelson; Kelly Delarosa; Usman Rahim; Meher Mavuram; Jesse J Xie; Caitlin C Murphy; Neehar D Parikh
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.